Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  MUMBAI STOCK EXCHANGE  >  Glaxosmithkline Pharmaceuticals Ltd    500660   INE159A01016

GLAXOSMITHKLINE PHARMACEUTICALS LTD

(500660)
  Report  
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mumbai Stock Exchange
09/16/2019 09/17/2019 09/18/2019 09/19/2019 09/20/2019 Date
1389.75 1366.65 1410.4 1396.4 1385.25 Last
7099 5077 7713 8854 10949 Volume
+1.97% -1.66% +3.20% -0.99% -0.80% Change
Financials (INR)
Sales 2020 34 638 M
EBIT 2020 6 661 M
Net income 2020 4 818 M
Finance 2020 10 998 M
Yield 2020 1,44%
Sales 2021 38 808 M
EBIT 2021 7 789 M
Net income 2021 5 459 M
Finance 2021 11 865 M
Yield 2021 2,06%
P/E ratio 2020 48,2x
P/E ratio 2021 41,6x
EV / Sales2020 6,46x
EV / Sales2021 5,74x
Capitalization 235 B
More Financials
Company
GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company and its subsidiary are engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in approximately three areas, including pharmaceuticals, vaccines... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Glaxosmithkline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
2011GLAXOSMITHKLINE PHARMACEUTICALS LIMI : GlaxoSmithKline Pharmaceuticals Net Sales..
PU
2011GLAXOSMITHKLINE PHARMACEUTICALS LIMI : announces launch of two drugs
PU
More news
Sector news : Pharmaceuticals - NEC
09/20DR REDDY LABORATORIES : . Reddy's Suspends Shipments of Ranitidine
DJ
09/20ALLERGAN : Form 8.3 -
DJ
09/20NOVO NORDISK : FDA Approves Novo Nordisk's Rybelsus Diabetes Tablets
DJ
09/20ZOETIS : Says EC Grants Marketing Authorization for Antiparasitic Medication for..
DJ
09/20MERCK : Pfizer Get CHMP Positive Opinion for Bavencio
DJ
More sector news : Pharmaceuticals - NEC
Chart GLAXOSMITHKLINE PHARMACEUTICALS LTD
Duration : Period :
Glaxosmithkline Pharmaceuticals Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 8
Average target price 1 156,67  INR
Last Close Price 1 385,25  INR
Spread / Highest target -6,88%
Spread / Average Target -16,5%
Spread / Lowest Target -23,8%
EPS Revisions
Managers
NameTitle
Annaswamy Vaidheesh Managing Director & Executive Director
Deepak Shantilal Parekh Non-Executive Chairman
Puja Thakur Chief Financial Officer & Executive Director
Bhavesh Kotak Executive Vice President-Medical
D. Sundaram Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PHARMACEUTICALS LTD-10.34%3 303
JOHNSON & JOHNSON2.01%347 446
ROCHE HOLDING LTD.16.27%245 289
MERCK AND COMPANY11.45%218 042
PFIZER-15.95%202 934
NOVARTIS15.60%199 009